Drug delivery technologies, including microparticles, nanoparticles, and nanotechnology, promise to create new treatments for cancer, heart disease, and other illnesses. Nanotechnology has proven effective for therapeutic DNA and RNA delivery, including the rapid development of nanoparticles for the COVID-19 mRNA vaccine and in vivo delivery of CRISPR gene editing therapy.

In this inaugural GEN Biotechnology webinar, we welcome our distinguished guest, Dr. Robert Langer, the David H. Koch Institute professor of chemical engineering at MIT and co-founder of Moderna. Professor Langer will discuss his early research on developing controlled release systems for macromolecules, leading to the isolation of the first angiogenesis inhibitors and methods for nanoparticle-based drug delivery. He will also cover the mRNA vaccine development timeline and effectiveness during the COVID-19 pandemic.